Registry Study Describes COVID‐19 Mortality and Hospitalization in Patients with Breast Cancer

Nearly half (48%) of patients with active breast cancer or a history of breast cancer and COVID‐19 were hospitalized and 9% died within 30 days of COVID‐19 diagnosis, according to new data from the COVID‐19 and Cancer Consortium registry study.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Conference Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869358/
https://www.ncbi.nlm.nih.gov/pubmed/33399255
http://dx.doi.org/10.1002/onco.13664
Descripción
Sumario:Nearly half (48%) of patients with active breast cancer or a history of breast cancer and COVID‐19 were hospitalized and 9% died within 30 days of COVID‐19 diagnosis, according to new data from the COVID‐19 and Cancer Consortium registry study.

Ejemplares similares